Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Blood Reviews
|
February 8, 2022
Current state and next-generation CAR-T cells in multiple myeloma
Salomon Manier, Tiziano Ingegnere, Guillaume Escure, et al.
Leukemia Research Reports
|
May 7, 2020
Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size
Celine Berthon, Morgane Nudel, Eileen M Boyle, et al.
Leukemia & Lymphoma
|
December 17, 2022
Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider
Alexandre Butelet, Stéphanie Poulain, Emmanuelle Jeanpierre, et al.
British Journal of Haematology
|
March 20, 2024
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO)
Kamel Laribi, Stéphanie Poulain, Lise Willems, et al.
Annals of Hematology
|
November 5, 2024
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström's macroglobulinemia
Cécile Tomowiak, Stéphanie Poulain, Morgane Nudel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2017
<i>TP53</i> Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia
Stéphanie Poulain, Christophe Roumier, Elisabeth Bertrand, et al.
International Journal of Antimicrobial Agents
|
March 5, 2019
Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort
Zoé Van de Wyngaert, Céline Berthon, Houria Debarri, et al.
American Journal of Hematology
|
August 19, 2015
Lenalidomide is safe and active in Waldenström macroglobulinemia
Guillemette Fouquet, Stéphanie Guidez, Marie-Odile Petillon, et al.
Cancer Medicine
|
May 31, 2019
Response to pneumococcal vaccination in multiple myeloma
Loïc Renaud, Susanna Schraen, Guillemette Fouquet, et al.
Blood Advances
|
March 21, 2024
Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression
Léa Fléchon, Inès Arib, Ankit K Dutta, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Blood Reviews
|
February 8, 2022
Current state and next-generation CAR-T cells in multiple myeloma
Salomon Manier, Tiziano Ingegnere, Guillaume Escure, et al.
Leukemia Research Reports
|
May 7, 2020
Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size
Celine Berthon, Morgane Nudel, Eileen M Boyle, et al.
Leukemia & Lymphoma
|
December 17, 2022
Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider
Alexandre Butelet, Stéphanie Poulain, Emmanuelle Jeanpierre, et al.
British Journal of Haematology
|
March 20, 2024
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO)
Kamel Laribi, Stéphanie Poulain, Lise Willems, et al.
Annals of Hematology
|
November 5, 2024
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström's macroglobulinemia
Cécile Tomowiak, Stéphanie Poulain, Morgane Nudel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2017
<i>TP53</i> Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia
Stéphanie Poulain, Christophe Roumier, Elisabeth Bertrand, et al.
International Journal of Antimicrobial Agents
|
March 5, 2019
Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort
Zoé Van de Wyngaert, Céline Berthon, Houria Debarri, et al.
American Journal of Hematology
|
August 19, 2015
Lenalidomide is safe and active in Waldenström macroglobulinemia
Guillemette Fouquet, Stéphanie Guidez, Marie-Odile Petillon, et al.
Cancer Medicine
|
May 31, 2019
Response to pneumococcal vaccination in multiple myeloma
Loïc Renaud, Susanna Schraen, Guillemette Fouquet, et al.
Blood Advances
|
March 21, 2024
Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression
Léa Fléchon, Inès Arib, Ankit K Dutta, et al.
Page
of 1